Podiatrists in West Lake Hills, TX Accepting Medicare

6 Podiatrists found. Showing 1 - 6

Austin Foot And Ankle Specialists Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 5000 Bee Caves Rd Ste 202, West Lake Hills, TX 78746 Phone: 512-328-8900    Fax: 512-328-8903

Austin Foot And Ankle Specialists Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 5000 Bee Caves Rd Ste 202, West Lake Hills, TX 78746 Phone: 512-328-8900    Fax: 512-328-8903

Dennis L. Berger, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 5656 Bee Caves Rd Ste D204, West Lake Hills, TX 78746 Phone: 512-447-2025    Fax: 512-447-4968

Dr. Ricardo Chica, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 5000 Bee Caves Rd Ste 202, West Lake Hills, TX 78746 Phone: 512-328-8900

Sharada D Penugonda, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 5656 Bee Caves Rd, D204, West Lake Hills, TX 78746 Phone: 512-327-9251    Fax: 512-327-9742

South Austin Foot Associates Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 5656 Bee Caves Rd Ste D204, West Lake Hills, TX 78746 Phone: 512-447-2025    Fax: 512-447-4968

News Archive

Helsinn, Mundipharma sign distribution and license agreement for investigational therapy

Helsinn and Mundipharma announce the signature of a new, exclusive license and distribution agreement, covering China, Hong Kong and Macao, for netupitant-palonosetron fixed dose combination, a Helsinn product under development for the treatment of chemotherapy-induced nausea and vomiting.

Brain enzyme blocks accumulation of tau proteins, slows down progression of neural degeneration

Increasing puromycin-sensitive aminopeptidase, the most abundant brain peptidase in mammals, slowed the damaging accumulation of tau proteins that are toxic to nerve cells and eventually lead to the neurofibrillary tangles, a major pathological hallmark of Alzheimer's disease and other forms of dementia, according to a study published online in the journal, Human Molecular Genetics.

Mutational profiling could determine which AML patients will benefit from dose-intensive chemotherapy

An international group of researchers, including those from Moffitt Cancer Center in Tampa, Fla., have published a paper in the March 14 issue of the New England Journal of Medicine reviewing the results of a study that analyzed mutations in 18 genes of 398 patients who had acute myeloid leukemia.

AtheroMed completes patient enrollment in EASE clinical study for treating PAD

AtheroMed, a developer of innovative technologies for treating peripheral artery disease, announced that it has completed patient enrollment in the EASE clinical study. The EASE study results will be presented by Dr. Stephen Williams, Director, Vascular Medicine Center at Johns Hopkins University, during a Late Breaking Clinical Trials Session on Wednesday, October 9th, at the Vascular Interventional Advances conference in Las Vegas.

Michigan Civil Rights Commission rules that small businesses must include birth control coverage

The Michigan Civil Rights Commission on Monday ruled that businesses that have fewer than 15 employees in the state and offer comprehensive prescription coverage to their employees must cover birth control prescriptions, the Detroit News reports.

Read more Medical News

› Verified 5 days ago